These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7526921)

  • 21. Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist.
    Vogensen SB; Jensen HS; Stensbøl TB; Frydenvang K; Bang-Andersen B; Johansen TN; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2000 Nov; 12(10):705-13. PubMed ID: 11054828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine.
    Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
    Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
    Stensbøl TB; Uhlmann P; Morel S; Eriksen BL; Felding J; Kromann H; Hermit MB; Greenwood JR; Braüner-Osborne H; Madsen U; Junager F; Krogsgaard-Larsen P; Begtrup M; Vedsø P
    J Med Chem; 2002 Jan; 45(1):19-31. PubMed ID: 11754576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
    Møller EH; Egebjerg J; Brehm L; Stensbøl TB; Johansen TN; Madsen U; Krogsgaard-Larsen P
    Chirality; 1999; 11(10):752-9. PubMed ID: 10561704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment.
    McCoy L; Richfield EK; Cory-Slechta DA
    J Neurochem; 1997 Dec; 69(6):2466-76. PubMed ID: 9375679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites.
    Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T
    J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
    Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacology of 3-isoxazolol amino acids as selective antagonists at group I metabotropic glutamic acid receptors.
    Madsen U; Bräuner-Osborne H; Frydenvang K; Hvene L; Johansen TN; Nielsen B; Sánchez C; Stensbøl TB; Bischoff F; Krogsgaard-Larsen P
    J Med Chem; 2001 Mar; 44(7):1051-9. PubMed ID: 11297452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the antagonist actions of (RS)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid (ATPO) on non-NMDA receptors in cultured rat neurones.
    Dai WM; Ebert B; Madsen U; Lambert JD
    Br J Pharmacol; 1998 Dec; 125(7):1517-28. PubMed ID: 9884081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists.
    Madsen U; Bang-Andersen B; Brehm L; Christensen IT; Ebert B; Kristoffersen IT; Lang Y; Krogsgaard-Larsen P
    J Med Chem; 1996 Apr; 39(8):1682-91. PubMed ID: 8648608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
    Frølund B; Greenwood JR; Holm MM; Egebjerg J; Madsen U; Nielsen B; Bräuner-Osborne H; Stensbøl TB; Krogsgaard-Larsen P
    Bioorg Med Chem; 2005 Sep; 13(18):5391-8. PubMed ID: 16043357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.
    Stensbøl TB; Jensen HS; Nielsen B; Johansen TN; Egebjerg J; Frydenvang K; Krogsgaard-Larsen P
    Eur J Pharmacol; 2001 Jan; 411(3):245-53. PubMed ID: 11164381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
    Vogensen SB; Clausen RP; Greenwood JR; Johansen TN; Pickering DS; Nielsen B; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 2005 May; 48(9):3438-42. PubMed ID: 15857151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA binding.
    Hawkinson JE; Espitia SA
    Eur J Pharmacol; 1997 Jun; 329(2-3):213-21. PubMed ID: 9226415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different characteristics of AMPA receptor agonists acting at AMPA receptors expressed in Xenopus oocytes.
    Wahl P; Madsen U; Banke T; Krogsgaard-Larsen P; Schousboe A
    Eur J Pharmacol; 1996 Jul; 308(2):211-8. PubMed ID: 8840134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
    Madsen U; Frydenvang K; Ebert B; Johansen TN; Brehm L; Krogsgaard-Larsen P
    J Med Chem; 1996 Jan; 39(1):183-90. PubMed ID: 8568805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
    Bjerrum EJ; Kristensen AS; Pickering DS; Greenwood JR; Nielsen B; Liljefors T; Schousboe A; Bräuner-Osborne H; Madsen U
    J Med Chem; 2003 May; 46(11):2246-9. PubMed ID: 12747796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S; Cebers G; Kalda A
    Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.